Related Experiment Video

Updated: Jun 1, 2026

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease
07:03

In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-Associated Steatotic Liver Disease

Published on: July 19, 2024

Mechanisms of lipotoxicity in NAFLD and clinical implications

Samar H Ibrahim1, Rohit Kohli, Gregory J Gores

  • 1Division of Pediatric Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, MN, USA.

Journal of Pediatric Gastroenterology and Nutrition
|June 2, 2011
PubMed

Insights

Childhood obesity epidemic fuels nonalcoholic fatty liver disease (NAFLD). Free fatty acids (FFAs) cause liver cell death via endoplasmic reticulum stress and mitochondrial pathways, driving NAFLD progression. Therapeutic targets focus on inhibiting these pathways.

Area of Science:

  • Hepatology
  • Pediatric Gastroenterology
  • Cellular Biology

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is the leading cause of pediatric chronic liver disease, linked to obesity and insulin resistance.
  • Serum free fatty acids (FFAs) contribute to NAFLD pathogenesis through direct hepatotoxicity.
  • Current therapies for pediatric NAFLD are limited, highlighting the need for novel treatment strategies.

Purpose of the Study:

  • To review the complex cellular mechanisms underlying free fatty acid (FFA)-induced lipotoxicity in nonalcoholic fatty liver disease (NAFLD).
  • To discuss potential therapeutic targets for halting NAFLD progression in children.
  • To explore interventions focusing on apoptosis, endoplasmic reticulum stress, and c-Jun-N-terminal kinase pathways.

Main Methods:

  • Literature review of cellular mechanisms in NAFLD pathogenesis.
  • Analysis of the role of free fatty acids (FFAs) in inducing hepatocyte cell death.
  • Discussion of potential therapeutic strategies targeting lipotoxicity pathways.

Main Results:

  • Free fatty acids (FFAs) induce hepatotoxicity via endoplasmic reticulum stress and mitochondrial apoptosis pathways.
  • Lipoapoptosis, driven by FFAs, correlates with inflammation and fibrosis in NAFLD.
  • Triglyceride accumulation is less hepatotoxic than FFA-induced cellular death mechanisms.

Conclusions:

  • Cellular mechanisms of lipotoxicity offer promising therapeutic targets for pediatric NAFLD.
  • Inhibiting apoptosis, endoplasmic reticulum stress, and JNK pathways may represent effective treatment strategies.
  • Further research into these pathways is crucial for developing effective therapies to halt NAFLD progression.

More Related Videos

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Inflammation01:38

Inflammation

Overview
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...